Related Experiment Videos
Some ethical and design challenges of screening programs and screening tests
1Pathology and Molecular Medicine, McMaster University, St. Joseph's Hospital, 50 Charlton Avenue East, L301-4, Hamilton, ON, Canada L8N 4A6. mcquemat@hhsc.ca
Clinica Chimica Acta; International Journal of Clinical Chemistry
|December 1, 2001
Summary
Obtaining informed consent for screening studies is challenging due to design flaws and consent issues. Clear communication of risks, benefits, and limitations is crucial for ethical presymptomatic screening.
Area of Science:
- Clinical Research Ethics
- Public Health Screening
Background:
- Numerous screening studies suffer from inadequate design and consent processes.
- Ethical considerations in clinical research are paramount.
Purpose of the Study:
- To highlight the importance of informed consent in presymptomatic screening.
- To address challenges in communicating screening efficacy, limitations, and potential discrimination.
Main Methods:
- Review of ethical principles for clinical interactions and research.
- Analysis of informed consent requirements in presymptomatic screening.
- Consideration of cultural differences in autonomy and consent.
Main Results:
- Informed consent requires clear, realistic information on harms, benefits, and test consequences.
- Coercion must be avoided; both written and oral information are important.
- Genetic testing presents unique challenges including counseling, confidentiality, and discrimination risks.
Conclusions:
- Presenting complex screening data understandably is increasingly difficult.
- Balancing participant comprehension with societal costs, efficacy, and efficiency is a significant challenge.